MENU
ATXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Astria Therapeutics (ATXS) Ownership - Who owns Astria Therapeutics?

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
75 State Street
Phone
+1 617 349-1971
Employees
59
Web
https://www.astriatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
718.13M
P/E Ratio
N/A
Total Cash
227.72M
Projected Growth
N/A
Total Debt
4.46M
Revenue
706K
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash/Share
3.99
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
75 State Street
Phone
+1 617 349-1971
Employees
59
Web
https://www.astriatx.com